Skip to content
10-Q

Quarterly Report

FENNEC PHARMACEUTICALS INC. FENC

0001104659-25-111260

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 28.12M sh
Shares Diluted Q3 2025 · Sep 30, 2025 27.89M sh
Shares Diluted Q3 2025 · Sep 30, 2025 27.71M sh
Shares Diluted Q3 2025 · Sep 30, 2024 27.37M sh
Shares Diluted Q3 2025 · Sep 30, 2024 28.02M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$6.51M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $28.45M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $21.95M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $26.63M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$4.49M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$7.46M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$5.88M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$5.87M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$5.17M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$1.36M
Stockholders Equity Q3 2025 · Mar 31, 2024 $3.01M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$11.62M
Current Liabilities Q3 2025 · Sep 30, 2025 $9.82M
Current Liabilities Q3 2025 · Dec 31, 2024 $6.92M
Total Liabilities Q3 2025 · Sep 30, 2025 $53.75M
Total Liabilities Q3 2025 · Dec 31, 2024 $50.82M
Current Assets Q3 2025 · Sep 30, 2025 $46.06M
Current Assets Q3 2025 · Dec 31, 2024 $44.12M
Total Assets Q3 2025 · Sep 30, 2025 $49.26M
Total Assets Q3 2025 · Dec 31, 2024 $44.95M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.02
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.18
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.21
Eps Diluted Q3 2025 · Sep 30, 2024 $0.06
Eps Basic Q3 2025 · Sep 30, 2025 −$0.02
Eps Basic Q3 2025 · Sep 30, 2025 −$0.18
Eps Basic Q3 2025 · Sep 30, 2024 −$0.21
Eps Basic Q3 2025 · Sep 30, 2024 $0.06
Sga Expense Q3 2025 · Sep 30, 2025 $6.75M
Sga Expense Q3 2025 · Sep 30, 2025 $19.85M
Sga Expense Q3 2025 · Sep 30, 2024 $6.12M
Sga Expense Q3 2025 · Sep 30, 2024 $18.86M
Rd Expense Q3 2025 · Sep 30, 2025 $29K
Rd Expense Q3 2025 · Sep 30, 2025 $230K
Rd Expense Q3 2025 · Sep 30, 2024 $97K
Rd Expense Q3 2025 · Sep 30, 2024 $257K
Net Income Q3 2025 · Sep 30, 2025 −$638K
Net Income Q3 2025 · Sep 30, 2025 −$4.95M
Net Income Q3 2025 · Jun 30, 2025 −$3.15M
Net Income Q3 2025 · Mar 31, 2025 −$1.17M
Net Income Q3 2025 · Sep 30, 2024 −$5.74M
Net Income Q3 2025 · Sep 30, 2024 $1.55M
Net Income Q3 2025 · Jun 30, 2024 −$5.55M
Net Income Q3 2025 · Mar 31, 2024 $12.84M
Operating Income Q3 2025 · Sep 30, 2025 −$189K
Operating Income Q3 2025 · Sep 30, 2025 −$3.73M
Operating Income Q3 2025 · Sep 30, 2024 −$5.2M
Operating Income Q3 2025 · Sep 30, 2024 $3.5M
Revenue Q3 2025 · Sep 30, 2025 $12.46M
Revenue Q3 2025 · Sep 30, 2025 $30.87M
Revenue Q3 2025 · Sep 30, 2024 $6.97M
Revenue Q3 2025 · Sep 30, 2024 $39.61M